Omalizumab for patients with severe and therapy-refractory atopic eczema?

Christian Andres; Benedetta Belloni; Martin Mempel; Johannes Ring

doi:10.1007/s11882-008-0029-3

Omalizumab for patients with severe and therapy-refractory atopic eczema?

Christian Andres, Benedetta Belloni, Martin Mempel, Johannes Ring

Default

Research output: Contribution to journal › Comment/debate

19 Scopus citations

Original language	English
Pages (from-to)	179-180
Number of pages	2
Journal	Current Allergy and Asthma Reports
Volume	8
Issue number	3
DOIs	https://doi.org/10.1007/s11882-008-0029-3
State	Published - May 2008

Access to Document

10.1007/s11882-008-0029-3

Cite this

@article{ae9d866bef4d402493ad777967edabaf,

title = "Omalizumab for patients with severe and therapy-refractory atopic eczema?",

author = "Christian Andres and Benedetta Belloni and Martin Mempel and Johannes Ring",

year = "2008",

month = may,

doi = "10.1007/s11882-008-0029-3",

language = "English",

volume = "8",

pages = "179--180",

journal = "Current Allergy and Asthma Reports",

issn = "1529-7322",